Obesity in China: What are the Causes?

Current Pharmaceutical Design

Volumn 17, Issue 12, 2011, Pages 1132-1139

  von Deneen, Karen M ^a,c   Wei, Qin ^a   Tian, Jie ^a,b   Liu, Yijun ^c  

^a XIDIAN UNIVERSITY   (China)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

China; Dyslipidemia; Hypertension; Insulin resistance; Metabolic syndrome; Obesity; Overweight; Type 2 diabetes mellitus

Indexed keywords

ARTICLE; BEHAVIOR CHANGE; CHILDHOOD DISEASE; CHILDHOOD OBESITY; CHINA; DIET; GENE; GENE INTERACTION; GROUPS BY AGE; HEALTH HAZARD; HUMAN; LIFESTYLE; METABOLIC SYNDROME X; MORTALITY; OBESITY; PRIORITY JOURNAL;

EID: 79958236211     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161211795656765     Document Type: Article

References (197)

1. Cecchini M, Sassi F, Lauer JA, Lee YY, Guajardo-Barron V, Chisholm D. Tackling of unhealthy diets, physical inactivity, andobesity: health effects and cost-effectiveness. Lancet 2010; 376:1775-84.
2. Popkin BM. The nutrition transition and obesity in the developingworld. J Nutr 2001; 131: 871S-873S.
3. Poskitt EM. Countries in transition: underweight to obesity nonstop? Ann Trop Paediat 2009; 29: 1-11.
4. Lu Y, Goldman D. The effects of relative food prices on obesity-evidence from China: 1991-2006. NBER Working Paper Series[w15720, 2010]. 2010 Dec 7; [cited 2010 February 1]. Available from: http://ssrn.com/abstract=1548778.
5. Lee SA, Wen W, Xu WH, et al. Prevalence of obesity and correlationswith lifestyle and dietary factors in Chinese men. Obesity(Silver Spring) 2008; 16: 1440-7.
6. Janus ED. Epidemiology of cardiovascular risk factors in HongKong. Clin Exp Pharmacol Physiol 1997; 24: 987-8.
7. Yang W, Lu J, Weng J, et al. Prevalence of diabetes among menand women in China. N Engl J Med 2010; 362: 1090-101.
8. Brown WV, Fujioka K, Wilson PW, Woodworth KA. Obesity: whybe concerned? Am J Med 2009; 122: S4-11.
9. Achike FI, To NH, Wang H, Kwan CY. Obesity, metabolic syndrome,adipocytes and vascular function: a holistic viewpoint. Clin Exp Pharmacol Physiol 2011; 38(1): 1-10.
10. Rossner S. Adolphe Quetelet (1796-1874). Obes Rev 2007;8(2):183.
11. WHO Consultation on Obesity. Obesity: preventing and managingthe global epidemic: report of a WHO consultation; 1999; Geneva,Switzerland: WHO technical report series 894.
12. Lee CD, Blair SN, Jackson AS. Cardiorespiratory fitness, bodycomposition, and all cause and cardiovascular disease mortality inmen. Am J Clin Nutr 1999; 69: 373-80.
13. Bray GA. In: Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD,Martin JB, Kasper DL, Hauser SL, Longo DL, Eds. Harrison's Principles of Internal Medicine. New York: McGraw-Hill. 1998;pp. 454-62.
14. Lean ME. Pathophysiology of obesity: Proc Nutr Soc 2000; 59(3):331-6.
15. Hyun YJ, Kim OY, Jang Y, et al. Evaluation of metabolic syndromerisk in Korean premenopausal women: not waist circumferencebut visceral fat. Circ J 2008; 72: 1308-15.
16. Li R, Lu W, Jia J, Zhang S, Shi L, Li Y: Relationships betweenindices of obesity and its cardiovascular comorbidities in a Chinesepopulation. Circ J 2008; 72: 973-8.
17. Shao J, Yu L, Shen X, Li D, Wang K. Waist-to-height ratio, anoptimal predictor for obesity and metabolic syndrome in Chineseadults. J Nutr Health Aging 2010; 14(9): 782-5.
18. Groschl M, Topf HG, Bohlender J, et al. Identification of ghrelin inhuman saliva: production by the salivary glands and potential rolein proliferation of oral keratinocytes. ClinChem 2005; 51: 997-1006.
19. English PJ, Ghatei MA, Malik IA, Bloom SR, Wilding JP. Foodfails to suppress ghrelin levels in obese humans. J Clin EndocrinolMetab 2002; 87: 2984.
20. Shiiya T, Nakazato M, Mizuta M, et al. Plasma ghrelin levels inlean and obese humans and the effect of glucose on ghrelin secretion. J Chin Endocrinol Metab 2002; 87:240-4.
21. Aydin S. A comparison of ghrelin, glucose, alpha-amylase andprotein levels in saliva from diabetics. J Biochem Mol Biol 2007;40: 29-35.
22. Fagerberg B, Hulten LM, Hulthe J. Plasma ghrelin, body fat, insulinresistance, and smoking in clinically healthy men: the atherosclerosisand insulin resistance study. Metabolism 2003; 52: 1460-3.
23. Li BB, Chen ZB, Li BC, et al. Expression of ghrelin in humansalivary glands and its levels in saliva and serum in Chinese obesechildren and adolescents. Arch Oral Biol 2010; [Epub ahead ofprint].
24. Srivastava S, Krueger KE. In: Wong, Ed. Salivary diagnostics.Iowa: Wiley-Blackwell Press 2008;.pp.94-103.
25. Bouchard C. Childhood obesity: are genetic differences involved? Amer J Clin Nutr 2009; 89: 1494S-1501S.
26. WHO Expert Consultation. WHO Technical Report Series 894:Obesity: preventing and managing the global epidemic; Geneva,Switzerland. World Health Organization 2000.
27. McMillen IC, Rattanatray L, Duffield JA, Morrison, et al. Theearly origins of later obesity: pathways and mechanisms. AdvanExp Med Biol 2009; 646: 71-81.
28. Martorell R, Stein AD, Schroeder DG. Early nutrition and lateradiposity. J Nutr 2001; 131: 874S-80S.
29. Mcauley KA, Williams SM, Mann JI, et al. Diagnosing insulinresistance in the general population. Diabetes Care 2001; 24: 460-4.
30. Thorleifsson G, Walters GB, Gudbjartsson DF, et al. Genome-wideassociation yields new sequence variants at seven loci that associatewith measures of obesity. Nat Genet 2009; 41: 18-24.
31. Willer CJ, Speliotes EK, Loos RJ, et al. Six new loci associatedwith body mass index highlight a neuronal influence on bodyweight regulation. Nat Genet 2009; 41: 25-34.
32. Scuteri A, Sanna S, Chen WM, et al. Genome-wide associationscan shows genetic variants in the FTO gene are associated withobesity-related traits. PLoS Genet 2007; 3:e115.
33. Frayling TM, Timpson NJ, Weedon MN, et al. A common variantin the FTO gene is associated with body mass index and predisposesto childhood and adult obesity. Science 2007; 316: 889-94.
34. Dina C, Meyre D, Gallina S, et al. Variation in FTO contributes tochildhood obesity and severe adult obesity. Nat Genet 2007; 39:724-6.
35. Loos RJ, Lindgren CM, Li S, et al. Common variants near MC4Rare associated with fat mass, weight and risk of obesity. Nat Genet 2008; 40: 768-75.
36. Chambers JC, Elliott P, Zabaneh D, et al. Common genetic variationnear MC4R is associated with waist circumference and insulinresistance. Nat Genet 2008; 40: 716-8.
37. Gerken T, Girard CA, Tung YC, et al. The obesity-associated FTOgene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science 2007; 318(5855): 1469-72.
38. Sanchez-Pulido L, Andrade-Navarro MA. The FTO (fat mass andobesity associated) gene codes for a novel member of the non-hemedioxygenase superfamily. BMC Biochem 2007; 8: 23.
39. Li H, Wu Y, Loos RJ, et al. Variants in the fat mass- and obesityassociated(FTO) gene are not associated with obesity in a ChineseHan population. Diabetes 2008; 57: 264-8.
40. Deng FY, Lei SF, Li MX, Jiang C, Dvornyk V, Deng HW. Geneticdetermination and correlation of body mass index and bone mineraldensity at the spine and hip in Chinese Han ethnicity. Osteoporos Int 2006; 17: 119-24.
41. Wu KD, Hsiao CF, Ho LT, et al. Clustering and heritability ofinsulin resistance in Chinese and Japanese hypertensive families: aStanford-Asian pacific program in hypertension and insulin resistancesibling study. Hypertens Res 2002; 25: 529-36.
42. Liu PY, Li YM, Li MX, et al. Lack of evidence for a major gene inthe Mendelian transmission of BMI in Chinese. Obes Res 2004; 12:1967-73.
43. Cheung CY, Tso AW, Cheung BM, et al. Obesity susceptibilitygenetic variants identified from recent genome-wide associationstudies: implications in a Chinese population. J Clin EndocrinolMetab 2010; 95(3): 1395-403.
44. Al-Attar SA, Pollex RL, Ban MR, et al. Association between theFTO rs9939609 polymorphism and the metabolic syndrome in anon-Caucasian multi-ethnic sample. Cardiovasc Diabetol 2008; 7:5.
45. Hubacek JA, Bohuslavova R, Kuthanova L, et al. The FTO geneand obesity in a large eastern European population sample: the HAPIEE study. Obesity (Silver Spring) 2008; 16: 2764-6.
46. Hotta K, Nakata Y, Matsuo T, et al. Variations in the FTO gene areassociated with severe obesity in the Japanese. J Hum Genet 2008;53: 546-53.
47. Grant SF, Li M, Bradfield JP, et al. Association analysis of theFTO gene with obesity in children of Caucasian and African ancestryreveals a common tagging SNP. PLoS One 2008; 3:e1746.
48. Kanehisa M, Goto S. KEGG: Kyoto encyclopedia of genes andgenomes. Nucleic Acids Res 2000; 28: 27-30.
49. Aravind L, Koonin EV. Fold prediction and evolutionary analysisof the POZ domain: structural and evolutionary relationship withthe potassium channel tetramerization domain. J Mol Biol 1999;285: 1353-61.
50. Ding XF, Luo C, Ren KQ, et al. Characterization and expression ofa human KCTD1 gene containing the BTB domain, which mediatestranscriptional repression and homomeric interactions. DNA CellBiol 2008; 27: 257-25.
51. Chang YC, Liu PH, Lee WJ, et al. Common variation in the fatmass- and obesity-associated (FTO) gene confers risk of obesityand modulates BMI in the Chinese population. Diabetes 2008;57(8): 2245-52.
52. Tan JT, Dorajoo R, Seielstad M, et al. FTO variants are associatedwith obesity in the Chinese and Malay populations in Singapore. Diabetes 2008; 57(10): 2851-7.
53. Fang H, Li Y, Du S, et al. Variant rs9939609 in the FTO gene isassociated with body mass index among Chinese children. BMC Medical Genetics 2010; 11: 136.
54. Li X, Song F, Jiang H, et al. A genetic variation in the fat mass-andobesity-associated gene is associated with obesity and newly diagnosedtype 2 diabetes in a Chinese population. Diabetes Metab ResRev 2010; 26(2): 128-32.
55. Xi B, Shen Y, Zhang M, et al. The common rs9939609 variant ofthe fat mass and obesity-associated gene is associated with obesityrisk in children and adolescents of Beijing, China. BMC MedGenet 2010; 11: 107.
56. Jellema A, Zeegers MP, Feskens EJ, et al. Gly972Arg variant inthe insulin receptor substrate-1 gene and association with type 2diabetes: a meta-analysis of 27 studies. Diabetologia 2003; 46(7):990-5.
57. Huang W, Sun Y, Sun J. Combined effects of FTO rs9939609 andMC4R rs17782313 on obesity and BMI in Chinese Han populations. Endocrine 2010; [Epub ahead of print].
58. Ng MC, Park KS, Oh B, et al. Implication of genetic variants nearTCF7L2,SLC30A8, HHEX, CDKAL1, CDKN2A/B, IDF2BP2 andFTO in type 2 diabetes and obesity in 6,719 Asians. Diabetes 2008;57(8): 2226-33.
59. Hara K, Boutin P, Mori Y, et al. Genetic variation in the geneencoding adiponectin is associated with an increased risk of type 2diabetes in the Japanese population. Diabetes 2002; 51: 536-40.
60. Vasseur F, Helbecque N, Dina C, et al. Single nucleotide polymorphismhaplotypes in the both proximal promoter and exon 3 of theADIPOQ gene modulate adipocyte-secreted adiponectin hormonelevels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet 2009; 11: 2607-14.
61. Gu HF, Abulaiti A, Ostenson CG, et al. Single nucleotide SNPs inthe proximal promoter region of the adiponectin (APM1) gene areassociated with T2D in Swedish Caucasians. Diabetes 2004;53(Suppl 1): 31-5.
62. Miyake K, Yang W, Hara K, et al. Construction of a predictionmodel for type 2 diabetes mellitus in the Japanese population basedon 11 genes with strong evidence of the association. J Hum Genet 2009; 54: 236-41.
63. Wang H, Wu M, Zhu W, et al. Evaluation of the association betweenthe AC3 genetic polymorphisms and obesity in a ChineseHan population. PLoS One 2010; 5(11): e13851.
64. Luo J, Hu FB. Time trends of obesity in pre-school children inChina from 1989 to 1997. Int J Obesity 2002; 26: 553-8.
65. Rhee K. Childhood overweight and the relationship between parentbehaviors, parenting style, and family functioning. Annals AmerAcad Pol Soc Sci 2008; 615: 11-37.
66. Shi Z, Liena N, Nirmal Kumara B, Holmboe-Ottesen G. Perceptionsof weight and associated factors of adolescents in Jiangsu Province, China. Public Health Nutr 2007; 10: 298-305.
67. Huang JS, Becerra K, Oda T. Parental ability to discriminate theweight status of children: results of a survey. Pediatrics 2007; 120:e112-9.
68. Maynard LM, Galuska DA, Blanck HM, Serdula MK. Maternalperceptions of weight status of children. Pediatrics 2003; 111:1226-31.
69. Campbell MW, Williams J, Hampton A., Wake M. Maternal concernand perceptions of overweight in Australian preschool-agedchildren. Med J Aust 2006; 184: 274-7.
70. Wen X, Hui SS. Chinese parents' perceptions of their children'sweights and their relationship to parenting behaviors. Child CareHealth Dev 2010; [Epub ahead of print].
71. Drucker RR, Hammer LD, Agras WS, Bryson S. Can mothersinfluence their child's eating behavior. J Dev Behav Pediatr 1999;20: 88-92.
72. Spruijt-Metz D, Lindquist CH, Birch LL, Fisher JO, Goran MI. Relation between mothers' child-feeding practices and children'sadiposity. Amer J Clin Nutr 2002; 75: 581-6.
73. Kong AP, Chow CC. Medical consequences of childhood obesity:a Hong Kong perspective. Res Sports Med 2010; 18: 1,16-25.
74. Kong AP, Choi KC, Ko GT, et al. Associations of overweight withinsulin resistance, beta-cell function and inflammatory markers inChinese adolescents. Pediatr Diabetes 9: 488-95.
75. Hancox R, Milne B, Poulton R. Association between child andadolescent television viewing and adult health: a longitudinal birthcohort study. Lancet 2004; 364: 257-62.
76. Hong J. The internationalization of television in China: an evolutionof ideology, society, and media since the reform. Westport,CT: Praeger Publishers 1998.
77. McNeal JU, Ji MF. Chinese children as consumers: an analysis oftheir new product information sources. J Consum Market 1999; 16:345.
78. Ji MF, McNeal JU. How Chinese children's commercials differfrom those of the United States: a content analysis. J Advert 2001;30: 79.
79. Zhang YB, Harwood J. Modernization and tradition in an age ofglobalization: cultural values in Chinese television commercials. J Commun 2004; 54: 156-72.
80. McNeal JU, Yeh C. Development of consumer behavior patternsamong Chinese children. J Consum Market 1997; 14: 45-59.
81. Wang Z, Zhai F, Du S, et al. Dynamic shifts in Chinese eatingbehaviors. Asia Pac J Clin Nutr 2008; 17: 123-30.
82. Li M, Dibley MJ, Sibbritt D, et al. Factors associated with adolescents'overweight and obesity at community, school and householdlevels in Xi'an City, China: results of hierarchical analysis. Eur JClin Nutr 2008; 62: 635-43.
83. Popkin BM, Conde W, Hou N, et al. Is there a lag globally inoverweight trends for children compared with adults? Obesity 2006; 14: 1846-53.
84. McGuire WJ. Input and output variables currently promising forconstructing persuasive communications. In: Rice RE, Atkin CK,Eds. Public Communication Campaigns. Thousand Oaks, CA: SagePublications 2001; pp. 22-48.
85. Schachter S. Obesity and eating. Science 1968; 161: 751-6.
86. Coon KA, Goldberg J, Rogers BL, et al. Relationships between useof television during meals and children's food consumption patterns. Pediatrics 2001; 107: E7.
87. Parvanta SA, Brown JD, Du S, Zimmer CR, Zhao X, Zhai F. Televisionuse and snacking behaviors among children and adolescentsin China. J Adolesc Health 2010; 46(4): 339-45.
88. Livingstone S. Young People and New Media. Thousand Oaks,CA: Sage Publications 2002.
89. Roberts DF, Foehr UG. Kids and Media in America. New York:Cambridge University Press 2004.
90. Waller CE, Du S, Popkin BM. Patterns of overweight, inactivity,and snacking in Chinese children. Obes Res 2003; 11: 957-61.
91. Grundy SM, Brewer B, Cleeman JI, Smith SC, Lenfant C. Definitionof metabolic syndrome: Report of the national heart, lung, andblood institute/American heart association conference on scientificissues related to definition. Circulation 2004; 109: 433-8.
92. Halberg N, Wernstedt I, Scherer PE. The adipocyte as an endocrinecell. Endocrinol Metab Clin North Am 2008; 37(3): 753-67.
93. Lin Y, Rajala MW, Berger JP, Moller DE, Barzilai N, Scherer PE.Hyperglycemia induced production of acute phase reactants in adiposetissue. J Biol Chem 2001; 276(45): 42077-83.
94. Berg AH, Lin Y, Lisanti MP, Scherer PE. Adipocyte differentiationinduces dynamic changes in NF-kappaB expression and activity.Am J Physiol Endocrinol Metab 2004; 287(6): E1178-88.
95. Unger RH. Lipotoxic diseases. Annu Rev Med 2002; 53: 319-36.
96. Rahmouni K, Correia ML, Haynes WG, Mark AL. Obesityassociatedhypertension: new insights into mechanisms. Hypertension 2005; 45(1): 9-14.
97. Knudson JD, Dincer UD, Dick GM, et al. Leptin resistance extendsto the coronary vasculature in prediabetic dogs and provides a protectiveadaptation against endothelial dysfunction. Am J Physiol Heart Circ Physiol 2005; 289(3): H1038-46.
98. Hall JE, Brands MW, Hildebrandt DA, Kuo J, Fitzgerald S. Role ofsympathetic nervous system and neuropeptides in obesity hypertension. Braz J Med Biol Res 2000; 33(6): 605-18.
99. Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin linksobesity to diabetes. Nature 2001; 409(6818): 307-12.
100. Singer G, Granger DN. Inflammatory responses underlying themicrovascular dysfunction associated with obesity and insulin resistance. Microcirculation 2007; 14(4-5): 375-87.
101. Silswal N, Singh AK, Aruna B, Mukhopadhyay S, Ghosh S, Ehtesham NZ. Human resistin stimulates the pro-inflammatory cytokinesTNF-alpha and IL-12 in macrophages by NF-kappaBdependentpathway. Biochem Biophys Res Commun 2005; 334(4):1092-101.
102. McTernan CL, McTernan PG, Harte AL, Levick PL, Barnett AH, Kumar S. Resistin, central obesity, and type 2 diabetes. Lancet 2002; 359(9300): 46-7.
103. Dave GS, Kalia K. Hyperglycemia induced oxidative stress in type-1 and type-2 diabetic patients with and without nephropathy. CellMol Biol 2007; 53: 68-78.
104. Lastra G, Manrique C. The expanding role of oxidative stress, reninangiotensin system, and beta-cell dysfunction in the cardiometabolicsyndrome and type 2 diabetes mellitus. Antioxid RedoxSignal 2007; 9: 943-54.
105. Kaneto H, Nakatani Y, Kawamori D, Miyatsuka T, Matsuoka TA. Involvement of oxidative stress and the JNK pathway in glucosetoxicity. Rev Diabet Stud 2004; 1: 165-74.
106. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight,obesity, and mortality from cancer in a prospectively studiedcohort of U.S. adults. N Engl J Med 2003; 348(17): 1625-38.
107. Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM. Fasting serumglucose level and cancer risk in Korean men and women. JAMA 2005; 293(2): 194-202.
108. Lukanova A, Bjor O, Kaaks R, et al. Body mass index and cancer:results from the northern Sweden health and disease cohort. Int JCancer 2006; 118(2): 458-66.
109. Giovannucci E. Modifiable risk factors for colon cancer. Gastroenterol Clin North Am 2002; 31: 925-43.
110. Limburg PJ, Anderson KE, Johnson TW, et al. Diabetes mellitusand subsite-specific colorectal cancer risks in the Iowa women'shealth study. Cancer Epidemiol Biomarkers Prev 2005; 14(1): 133-7.
111. Ahmed RL, Schmitz KH, Anderson KE, Rosamond WD, Folsom AR. The metabolic syndrome and risk of incident colorectal cancer. Cancer 2006; 107(1): 28-36.
112. Colangelo LA, Gapstur SM, Gann PH, Dyer AR, Liu K. Colorectalcancer mortality and factors related to the insulin resistance syndrome. Cancer Epidemiol Biomarkers Prev 2002; 11(4): 385-91.
113. Kim JH, Lim YJ, Kim YH, et al. Is metabolic syndrome a riskfactor for colorectal adenoma? Cancer Epidemiol Biomarkers Prev 2007; 16(8): 1543-6.
114. Lee GE, Park HS, Yun KE, et al. Association between BMI andmetabolic syndrome and adenomatous colonic polyps in Koreanmen. Obesity (Silver Spring) 2008; 16(6): 1434-9.
115. Wang YY, Lin SY, Lai WA, Liu PH, Sheu WH. Association betweenadenomas of rectosigmoid colon and metabolic syndromefeatures in a Chinese population. J Gastroenterol Hepatol 2005;20(9): 1410-5.
116. Liu CS, Hsu HS, Li CI, et al. Central obesity and atherogenicdyslipidemia in metabolic syndrome are associated with increasedrisk for colorectal adenoma in a Chinese population. BMC Gastroenterol 2010; 10:51.
117. Cowey S, Hardy RW. The metabolic syndrome: a high-risk statefor cancer? Am J Pathol 2006; 169(5): 1505-22.
118. Gunter MJ, Canzian F, Landi S, Chanock SJ, Sinha R, Rothman N. Inflammation-related gene polymorphisms and colorectal adenoma. Cancer Epidemiol Biomarkers Prev 2006; 15(6): 1126-31.
119. Kim S, Keku TO, Martin C, et al. Circulating levels of inflammatorycytokines and risk of colorectal adenomas. Cancer Res 2008;68(1): 323-8.
120. Trevisan M, Liu J, Muti P, Misciagna G, Menotti A, Fucci F. Markers of insulin resistance and colorectal cancer mortality. CancerEpidemiol Biomarkers Prev 2001; 10(9): 937-41.
121. Fukushima M, Usami M, Ikeda M, et al. Insulin secretion andinsulin sensitivity at different stages of glucose tolerance: a crosssectionalstudy of Japanese type 2 diabetes. Metabolism 2004; 53:831-5.
122. Rhee SY, Kwon MK, Park BJ, et al. Differences in insulin sensitivityand secretory capacity based on OGTT in subjects with impairedglucose regulation. Korean J Intern Med 2007; 22: 270-4.
123. Liu J, Li YB, Shao H, et al. Evaluation of islet beta cell function insubjects with normal glucose tolerance, impaired glucose regulation,and type 2 diabetes mellitus. Zhonghua Yi Xue Za Zhi 2007;15: 1252-5.
124. Qian L, Xu L, Wang X, Fu, et al. Early insulin secretion failureleads to diabetes in Chinese subjects with impaired glucose regulation. Diabetes Metab Res Rev 2009; 25: 144-9.
125. Han XY, Ji LN, Zhou XH. Cross-sectional study of the pathophysiologicand clinical features in the first-degree relatives of type2 diabetic patients. Beijing Da Xue Xue Bao 2005; 37: 159-62.
126. Yang W, Lu J, Weng J, et al. China national diabetes and metabolicdisorders study group: prevalence of diabetes among men andwomen in China. N Engl J Med 2010; 362: 1090-101.
127. Jia WP, Xiang KS, Chen L, Lu JX, Wu YM. Epidemiological studyon obesity and its comorbidities in urban Chinese older than 20years of age in Shanghai, China. Obes Rev 2002; 3: 157-65.
128. Wang C, Tan H, Yu H, et al. Impairment of insulin action in nonobese,normal-glucose tolerant, first-degree relatives of Chinesetype 2 diabetic patients. Diabetes Res Clin Pract 2011; 91(1): 67-71.
129. Li HL, Yu YR, Yu HL, Wang C, Zhang XX. Relationship betweenperipheral insulin resistance and beta-cell function in obese subjects. Sichuan Da Xue Xue Bao Yi Xue Ban 2005; 36: 378-81.
130. Perseghin G, Ghosh S, Gerow K, Shulman GI. Metabolic defects inlean nondiabetic offspring of NIDDM parents. Diabetes 1997; 146:1001-9.
131. Van Haeften TW, Dubbeldam S, Zonderland ML, Erkelens DW. Insulin secretion in normal glucose-tolerant relatives of type 2 diabeticsubjects. Diabetes care 1998; 21: 278-82.
132. Hu FB, Manson JE, Stampfer MJ, et al. Diet, lifestyle, and the riskof type 2 diabetes mellitus in women. N Engl J Med 2001; 345(11):790-7.
133. Xu H, Song Y, You NC, et al. Prevalence and clustering of metabolicrisk factors for type 2 diabetes among Chinese adults in Shanghai, China. BMC Public Health 2010; 10: 683.
134. Janssen I, Katzmarzyk PT, Ross R. Body mass index, waist circumference,and health risk: evidence in support of current national institutesof health guidelines. Arch Intern Med 2002; 162: 2074-9.
135. Ardern CI, Katzmarzyk PT, Janssen I, et al. Discrimination ofhealth risk by combined body mass index and waist circumference. Obes Res 2003; 11: 135-42.
136. Department of Disease Control Ministry of Health, P.R. China. Theguidelines for prevention and control of overweight and obesity inChinese adults. Biomed Environ Scienc 2004; Suppl 17: 1-36.
137. Corporative Meta-analysis Group of China Obesity Task Force. Predictive values of body mass index and waist circumference torisk factors of related diseases in Chinese adult population. Chin J Epidemiol 2003; 23: 5-10.
138. Du SM, Ma GS, Li YP, et al. Relationship of body mass index,waist circumference and cardiovascular risk factors in Chineseadult. Biomed Environ Sci 2010; 23(2): 92-101.
139. Ko GT, Chow CC, Leung G, et al. High rate of increased carotidintima-media thickness and atherosclerotic plaques in Chinese asymptomaticsubjects with central obesity. Int J Cardiovasc Imaging 2010; [Epub ahead of print].
140. Yu Z, Lin X, Haas JD, et al. Obesity related metabolic abnormalities:distribution and geographic differences among middle-agedand older Chinese populations. Prev Med 2009; 48: 272-8.
141. Mi J, Cheng H, Zhao XY, Hou DQ, Chen FF, Zhang KL. Developmentalorigin of metabolic syndrome: interaction of thinness atbirth and overweight during adult life in Chinese population. ObesRev 2008; 9(Suppl 1): 91-4.
142. Kokubo Y, Okamura T, Yoshimasa Y, et al. Impact of metabolicsyndrome components on the incidence of cardiovascular disease ina general urban Japanese population: the suita study. Hypertens Res 2008; 31: 2027-35.
143. Wang J, Li H, Franco OH, Yu Z, Liu Y, Lin X. Adiponectin andmetabolic syndrome in middle-aged and elderly Chinese. Obesity(Silver Spring) 2008; 16: 172-8.
144. Liu H, Zhang X, Feng X, Li J, Hu M, Yambe T. Effects of metabolicsyndrome on cardio-ankle vascular index in middle-aged andelderly Chinese. Metab Syndr Relat Disord 2010; [Epub ahead ofprint].
145. Popkin BM, Paeratakul S, Zhai F, Ge K. A review of dietary andenvironmental correlates of obesity with emphasis on developingcountries. Obes Res 1995; 3(Suppl 2): 145s-53s.
146. Wu Y. Overweight and obesity in China. BMJ 2006; 333: 362-3.
147. Chen CM. Eating patterns-a prognosis for China. Asia Pac J ClinNutr 1995; 4(Supp 1): 24-8.
148. Paeratakul S, Popkin BM, Keyou G, Adair LS, Stevens J. Changesin diet and physical activity affect the body mass index of Chineseadults. Int J Obes Relat Metab Disord 1998; 22: 424-31.
149. Shankar B. Obesity in China: the differential impacts of covariatesalong the BMI distribution. Obesity 2010; 18(8):1660-6.
150. Joint FAO/WHO Expert Consultation. WHO Technical ReportSeries 916: Diet, Nutrition and the prevention of chronic diseases;Geneva, Switzerland. World Health Organization 2003.
151. Zhai F, Wang H, Du S, et al. Prospective study on nutrition transitionin China. Nutr Rev 2009; 67: S56-61.
152. Madanat HN, Troutman KP, Al-Madi B. The nutrition transition inJordan: the political, economic and food consumption contexts. Promotion et Educ 2008; 15: 6-10.
153. Drewnowski A. Obesity, diets, and social inequalities. Nutr Rev 2009; 67: S36-9.
154. Jones N, Furlanetto DL, Jackson JA, Kinn S. An investigation ofobese adults' views of the outcomes of dietary treatment. J HumanNutr Diet 2007; 20: 486-94.
155. James WP. The fundamental drivers of the obesity epidemic. Obes Rev 2008; 9: 6-13.
156. Misra A, Khurana L. Obesity and the metabolic syndrome in developingcountries. J Clin Endocrinol Metab 2008; 93: S9-30.
157. Olsen NJ, Heitmann BL. Intake of calorically sweetened beveragesand obesity. Obes Rev 2009; 10: 68-75.
158. Ko GT, So WY, Chow CC, et al. Risk associations of obesity withsugar-sweetened beverages and lifestyle factors in Chinese: the'Better Health for Better Hong Kong' health promotion campaign. Eur J Clin Nutrition 2010; 64: 1386-92.
159. Ariza AJ, Chen EH, Binns HJ, Christoffel KK. Risk factors foroverweight in five-to six-year-old Hispanic-American children: apilot study. J Urban Health 2004; 81: 150-61.
160. Berkey CS, Rockett HR, Field AE, Gillman MW, Colditz GA. Sugar-added beverages and adolescent weight change. Obes Res 2004; 12: 778-88.
161. Murakami K, Sasaki S, Takahashi Y, et al. Dietary glycemic indexand load in relation to metabolic risk factors in Japanese femalefarmers with traditional dietary habits. Am J Clin Nutr 2006; 83:1161-9.
162. Villegas R, Liu S, Gao YT, et al. Prospective study of dietary carbohydrates,glycemic index, glycemic load, and incidence of type 2diabetes mellitus in middle-aged Chinese women. Arch Intern Med 2007; 167: 2310-6.
163. Guldan, GS. Asian children's obesogenic diets-time to change thispart of the energy balance equation? Res Sports Med 2010; 18: 1,5-15.
164. Corvalan C, Dangour AD, Uauy R. Need to address all forms ofchildhood malnutrition with a common agenda. Arch Dis Child 2008; 93(5): 361-2.
165. Li Y, Zhai F, Yang X, et al. Determinants of childhood overweightand obesity in China. British J Nutr 2007; 97: 210-5.
166. Shi Z, Lien N, Kumar BN, Holmboe-Ottesen G. Sociodemographicdifferences in food habits and preferences of schooladolescents in Jiangsu Province, China. Eur J Clin Nutr 2005; 59:1439-48.
167. Ding EL, Malik VS. Convergence of obesity and high glycemicdiet on compounding diabetes and cardiovascular risks in modernizingChina: an emerging public health dilemma. Globalization andHealth 2008; 4: 4.
168. Kurihara K, Kashiwayanagi M. Physiological studies on umamitaste. J Nutr 2000; 130(Suppl 4): 931S-34S.
169. Smriga M, Torii K. Release of hypothalamic norepinephrine duringMSG intake in rats fed normal and nonprotein diet. Physiol Behav 2000; 70: 413-5.
170. Vazquez M, Pearson PB, Beauchamp GK. Flavour preferences inmalnourished Mexican infants. Physiol Behav 1981; 28: 513-9.
171. Murphy C. Aging and chemosensory perception of and preferencefor nutritionally significant stimuli. Ann N Y Acad Sci 1989; 561:251-66.
172. Mori M, Kawada T, Ono T, et al. Taste preference and proteinnutrition and L-amino acid homeostasis in male Sprague-Dawleyrats. Physiol Behav 1991; 49: 987-95.
173. Laska M, Hernandez Salazar LT. Gustatory responsiveness tomonosodium glutamate and sodium chloride in four species ofnonhuman primates. J Exp Zool A Comp Exp Biol 2004; 301: 898-905.
174. Food standards Australia New Zealand (2003) monosodium glutamate-a safety report. technical report (series no. 23); June 2003[updated 2011 February 3; cited 2011 Feb 1]. Available from:http://www.foodstandards.gov.au
175. Walker R, Lupien JR. The safety evaluation of monosodium glutamate. J Nutr 2000; 130(Suppl 4S): 1049S-52S.
176. Olney JW, Sharpe LG. Brain lesions in an infant rhesus monkeytreated with monosodium glutamate. Science 1969; 166: 386-8.
177. Olney JW. Brain lesions, obesity, and other disturbances in micetreated with monosodium glutamate. Science 1969; 164: 719-21.
178. Hermanussen M, Garcia AP, Sunder M, et al. Obesity, voracity,and short stature: the impact of glutamate on the regulation of appetite. Eur J Clin Nutr 2006; 60: 25-31.
179. Shi Z, Luscombe-Marsh ND, Wittert GA, et al. Monosodium glutamateis not associated with obesity or a greater prevalence ofweight gain over 5 years: findings from the Jiangsu Nutrition Studyof Chinese adults. Br J Nutr 2010; 104: 457-63.
180. Essed NH, van Staveren WA, Kok FJ, et al. No effect of 16 weeksflavour enhancement on dietary intake and nutritional status ofnursing home elderly. Appetite 2007; 48: 29-36.
181. Jumabay M, Kawamura H, Mitsubayashi H, et al. Urinary electrolytesand hypertension in elderly Kazakhs. Clin Exp Nephrol 2001;5: 217-21.
182. Wang K, Ao YT, Zhao L, et al. Analysis on obesity and its riskfactors among inhabitants of Bortala prefecture of Xinjiangautonomous region. Chinese J Public Health 2006; 22(9): 1128-30.
183. Xi B, Mi J. FTO polymorphisms are associated with obesity but notwith diabetes in East Asian populations: a meta-analysis. Biomed Environ Sci 2009; 22(6): 449-57.
184. Fu D, Wang J, Chen W, Bi Y: Disordered eating attitudes andbehaviours and related mood states among female university studentsin Beijing. Chin Ment Health J 2005; 19(8): 525-8.
185. Liang X, Guo L, Liu K. A cross-sectional investigation on eatingdisorders in 1486 female students from universities, senior highschools and junior high schools in Chengdu. Chin J Epidemiol 2008; 29(4): 321-4.
186. Lu X, Zhang N. Research on adolescents' eating behaviors andeating disorders. Master degree paper of Nanjing Normal University 2006; 2: 35-8.
187. Qian M, Liu X. Dieting and eating disorder of female students incolleges in Beijing. Chin Ment Health J 2002; 16(11): 753-7.
188. Xiao G, Qian M, Huon G, Wang Y. Rate of eating disorder inBeijing girls. Chin Ment Health J 2001; 15(5): 362-4.
189. Fan Y, Li Y, Liu A, Hu X, Ma G, Xu G. Associations betweenbody mass index, weight control concerns and behaviors, and eatingdisorder symptoms among non-clinical Chinese adolescents. BMC Public Health 2010; 10: 314.
190. Burrows A, Cooper M. Possible risk factors in the development ofeating disorders in overweight pre-adolescent girls. Inter J Obes 2002; 26(9): 1268-73.
191. Fairburn C, Welch S, Doll H, Davies B, O'Connor M. Risk factorsfor bulimia nervosa: a community-based, case-control study. ArchGen Psychiatry 1997; 54(6): 509-17.
192. Fairburn C, Doll H, Welch S, Hay P, Davies B, O'Connor M. Riskfactors for binge eating disorder: a community-based, case-controlstudy. Arch Gen Psychiatry 1998; 55(5): 425-32.
193. Striegel-Moore R, Fairburn C, Wilfley D, Pike K, Dohm F, Kraemer H. Toward an understanding of risk factors for binge-eatingdisorder in black and white women: a community-based casecontrolstudy. Psychol Med 2005; 35(6): 907-17.
194. Bas M, Bozan N, Cigerim N. Dieting, dietary restraint, and bingeeating disorder among overweight adolescents in Turkey. Adolescence 2008; 43(171): 635-48.
195. Neumark-Sztainer D, Story M, Hannan P, Perry C, Irving L. Weight-related concerns and behaviors among overweight andnonoverweight adolescents implications for preventing weightrelateddisorders. Arch Pediatr Adolesc Med 2002; 156(2): 171-8.
196. Neumark-Sztainer D, Wall M, Eisenberg M, Story M, Hannan P. Overweight status and weight control behaviors in adolescents:longitudinal and secular trends from 1999 to 2004. Prev Med 2006;43(1): 52-9.
197. Ge K, Weisell R, Guo X, et al. The body mass index of Chineseadults in the 1980s. Eur J Clin Nutr 1994; 48(Suppl 3): S148-54.